JP Morgan Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $14.9M | Buy |
+198,676
| New | +$15.3M | 0.04% | 312 |
|
|
2023
Q2 | – | Sell |
-230,067
| Closed | -$19.1M | – | 1635 |
|
|
2023
Q1 | $19.1M | Sell |
230,067
-8,028
| -3% | -$665K | 0.04% | 315 |
|
|
2022
Q4 | $20.4M | Sell |
238,095
-6,661
| -3% | -$527K | 0.05% | 303 |
|
|
2022
Q3 | $15.1M | Sell |
244,756
-1,965
| -0.8% | -$124K | 0.04% | 324 |
|
|
2022
Q2 | $15.3M | Sell |
246,721
-14,911
| -6% | -$923K | 0.04% | 326 |
|
|
2022
Q1 | $15.6M | Sell |
261,632
-5,298
| -2% | -$339K | 0.03% | 358 |
|
|
2021
Q4 | $19.4M | Sell |
266,930
-17,341
| -6% | -$1.19M | 0.04% | 323 |
|
|
2021
Q3 | $19.9M | Buy |
284,271
+22,875
| +9% | +$1.61M | 0.05% | 309 |
|
|
2021
Q2 | $18M | Sell |
261,396
-10,010
| -4% | -$668K | 0.05% | 323 |
|
|
2021
Q1 | $17.5M | Sell |
271,406
-38,501
| -12% | -$2.48M | 0.06% | 292 |
|
|
2020
Q4 | $18.1M | Sell |
309,907
-83,886
| -21% | -$5.06M | 0.06% | 276 |
|
|
2020
Q3 | $24.9M | Sell |
393,793
-53,693
| -12% | -$3.72M | 0.1% | 191 |
|
|
2020
Q2 | $34.4M | Buy |
447,486
+20,481
| +5% | +$1.57M | 0.16% | 138 |
|
|
2020
Q1 | $31.9M | Buy |
427,005
+105,963
| +33% | +$7.32M | 0.18% | 124 |
|
|
2019
Q4 | $20.9M | Sell |
321,042
-29,392
| -8% | -$1.91M | 0.09% | 193 |
|
|
2019
Q3 | $22.2M | Buy |
350,434
+19,554
| +6% | +$1.28M | 0.12% | 169 |
|
|
2019
Q2 | $22.4M | Sell |
330,880
-94,146
| -22% | -$6.19M | 0.12% | 169 |
|
|
2019
Q1 | $27.6M | Buy |
425,026
+1,805
| +0.4% | +$120K | 0.14% | 155 |
|
|
2018
Q4 | $26.5M | Sell |
423,221
-82,320
| -16% | -$5.75M | 0.16% | 142 |
|
|
2018
Q3 | $39M | Buy |
505,541
+4,472
| +0.9% | +$338K | 0.19% | 124 |
|
|
2018
Q2 | $35.5M | Sell |
501,069
-45,997
| -8% | -$3.25M | 0.2% | 125 |
|
|
2018
Q1 | $41.2M | Buy |
547,066
+20,361
| +4% | +$1.62M | 0.28% | 88 |
|
|
2017
Q4 | $37.7M | Buy |
526,705
+11,453
| +2% | +$870K | 0.25% | 100 |
|
|
2017
Q3 | $41.7M | Buy |
515,252
+118,970
| +30% | +$9.1M | 0.3% | 88 |
|
|
2017
Q2 | $28M | Sell |
396,282
-32,494
| -8% | -$2.16M | 0.21% | 114 |
|
|
2017
Q1 | $29.1M | Sell |
428,776
-23,067
| -5% | -$1.62M | 0.23% | 106 |
|
|
2016
Q4 | $32.4M | Sell |
451,843
-130,301
| -22% | -$9.69M | 0.28% | 92 |
|
|
2016
Q3 | $46.1M | Sell |
582,144
-105,295
| -15% | -$8.55M | 0.43% | 65 |
|
|
2016
Q2 | $57.3M | Sell |
687,439
-45,927
| -6% | -$4.08M | 0.56% | 51 |
|
|
2016
Q1 | $67.4M | Buy |
733,366
+93,775
| +15% | +$8.46M | 0.64% | 39 |
|
|
2015
Q4 | $64.7M | Buy |
639,591
+40,051
| +7% | +$4.17M | 0.66% | 40 |
|
|
2015
Q3 | $58.9M | Buy |
599,540
+14,290
| +2% | +$1.59M | 0.74% | 36 |
|
|
2015
Q2 | $68.5M | Buy |
585,250
+26,066
| +5% | +$2.85M | 0.79% | 29 |
|
|
2015
Q1 | $54.9M | Buy |
559,184
+39,678
| +8% | +$4.03M | 0.63% | 42 |
|
|
2014
Q4 | $49M | Buy |
519,506
+65,892
| +15% | +$6.81M | 0.58% | 44 |
|
|
2014
Q3 | $48.3M | Buy |
453,614
+22,855
| +5% | +$2.24M | 0.62% | 41 |
|
|
2014
Q2 | $35.7M | Buy |
430,759
+88,495
| +26% | +$6.89M | 0.6% | 44 |
|
|
2014
Q1 | $24.3M | Buy |
342,264
+95,440
| +39% | +$7.49M | 0.44% | 64 |
|
|
2013
Q4 | $18.5M | Buy |
246,824
+10,600
| +4% | +$738K | 0.37% | 84 |
|
|
2013
Q3 | $14.9M | Buy |
236,224
+7,629
| +3% | +$456K | 0.34% | 91 |
|
|
2013
Q2 | $11.7M | Buy |
+228,595
| New | +$11.9M | 0.29% | 101 |
|
Other funds holding GILD
JP Morgan Private Wealth Advisors's GILD Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors opened a new position in Gilead Sciences (GILD) in Q3 2023: 198,676 shares worth $14.9M. The stake represents 0.04% of the portfolio and ranks #312 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in GILD as recently as Q1 2023.
JP Morgan Private Wealth Advisors first reported a position in GILD in Q2 2013 and has held it in 41 quarters since. The position peaked at $68.5M in Q2 2015. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- JP Morgan Private Wealth Advisors held 198,676 shares of Gilead Sciences worth $14.9M as of Q3 2023.
- Gilead Sciences was a new JP Morgan Private Wealth Advisors position in Q3 2023.
- Gilead Sciences made up 0.04% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #312 holding.
- JP Morgan Private Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 41 quarters since.
- JP Morgan Private Wealth Advisors's Gilead Sciences position peaked at $68.5M in Q2 2015.
- 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.